Grymonpre R E, Sitar D S, Montgomery P R, Mitenko P A, Aoki F Y
Department of Medicine, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
DICP. 1991 Feb;25(2):186-90. doi: 10.1177/106002809102500214.
We report an analysis of prescription drugs claimed under a government-sponsored, universal Pharmacare program for community-dwelling adults aged greater than or equal to 50 years in Manitoba during 1975, 1978, 1981, and 1984. We limited our analysis to claimants who reported over six drugs in a year in order to control for effects of inflation and a changing deductible. The median number of prescribed drugs and the percent of claimants over age 50 years receiving prescriptions from multiple physicians decreased during the course of our study. In this sample of heavy drug users, age and sex did not consistently correlate with overall drug use, although there was correlation for specific drug groups. The relative ranking of prescribed drugs changed over the years, although benzodiazepines, thiazide diuretics, topical steroids, and codeine-containing analgesics remained near the top. Barbiturates and topical antibiotics showed the greatest drop in prescription rates; acetaminophen and beta-blockers increased the most. Using these community data, we project the prevalence of drug-related adverse events to be highest with beta-blockers, nonsteroidal antiinflammatory drugs, thiazide diuretics, and benzodiazepines.
我们报告了一项对1975年、1978年、1981年和1984年在曼尼托巴省参加政府资助的全民药物保险计划的50岁及以上社区居住成年人所申领的处方药的分析。我们将分析局限于那些报告一年中使用超过六种药物的申领者,以便控制通货膨胀和免赔额变化的影响。在我们的研究过程中,处方药的中位数数量以及50岁以上从多位医生处获得处方的申领者百分比有所下降。在这个大量用药者样本中,年龄和性别与总体药物使用并没有始终如一的相关性,尽管特定药物组存在相关性。多年来所开处方药的相对排名发生了变化,尽管苯二氮䓬类药物、噻嗪类利尿剂、外用类固醇和含可待因的镇痛药仍名列前茅。巴比妥类药物和外用抗生素的处方率下降幅度最大;对乙酰氨基酚和β受体阻滞剂的增加幅度最大。利用这些社区数据,我们预计与药物相关的不良事件发生率最高的药物为β受体阻滞剂、非甾体抗炎药、噻嗪类利尿剂和苯二氮䓬类药物。